SS-31 (Elamipretide) × nurapeptide.com — lab test, June 2026
COA 2606110366 matches freedomdiagnosticstesting.com's public record. So this test doesn't rest on our review alone — the lab confirms it too.
Nura2606110366Test results
This is a purity and identity analysis. Sterility, endotoxins, and heavy metals were not screened — a high purity figure says nothing about those.
About this test
Label 50 mg · Lab measured 53.25 mg
107% of label, basis not stated — shown as printed. Reconstituted with 2 mL, a 50-unit draw holds 13.3 mg using the measured mass, against 12.5 mg on the label — 7% more.
One vial from this lot was weighed by the laboratory, not yours. This page reports what the certificate says; it does not recommend a dose.
| Report number | 2606110366 |
|---|---|
| Portal lookup | ✓ Lab-verified |
| Checked | 30 Jul 2026date taken from the record, not from a logged check |
| Checked by | Peptigrity staff, against the lab's portal |
| PDF vs portal | freedomdiagnosticstesting.com's portal shows validity only |
| Weight | Counts as one lab test |
Independent HPLC purity analysis of SS-31 (Elamipretide) from nurapeptide.com, performed by freedomdiagnosticstesting.com on June 14, 2026. Reported purity: 99.74%. Net content: 53.25 mg against 50 mg labeled (107% of label). Endotoxins: Pass (≤0.05 EU/mL). Batch SS50-062026-1. Sample source: shop-provided. Certificate of analysis attached.
Certificate of analysis
Other lots of SS-31 (Elamipretide) from nurapeptide.com
| Lot | Tested | Lab | Purity | vs label | Status |
|---|---|---|---|---|---|
| SMX-062026-1 | 14 Jun 2026 | freedomdiagnosticstesting.com | 99.81% | 115% | ✓ Lab-verified |
| SS31500426 | 9 Apr 2026 | freedomdiagnosticstesting.com | 99.815% | 105% | ✓ Lab-verified |
Batches this shop has published a certificate for, newest first. A lot whose printed value cannot identify a batch is not listed.
Have you tested this peptide?
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.
Community discussion